Raymond GoodrichFounder

United States - Fort Collins, Colorado

My research program is focused on using new methods to stimulate immune response in patients with cancer and as a means to prevent infectious diseases. The first clinical application of new technology developed in my lab is for treatment of patients with advanced stage ovarian cancer. In addition, my group is focused on developing methods to generate new vaccine candidates for infectious diseases in humans and animals. Our current program of work includes research on new vaccine formulations for SARS-CoV-2, Tuberculosis, Influenza and African Swine Fever, using a technology platform for production of vaccines that I invented with colleagues at Colorado State University.

As the Executive Director Infectious Disease Research Center, Colorado State University from 2016 to 2023, served as the primary contact for all external and internal partners in infectious disease research. Responsible for managing relationships with external laboratories. Overall strategic responsibility for the IDRC and coordination of development and enhancement of infectious disease research and start-up companies. Oversight of BioMARC, an FDA-inspected bio-manufacturing facility. Focused on lowering translational barriers for CSU researchers as well as managing the financial aspects, teaching and training for faculty in the IDRC.

Co-Founder of PhotonPharma, Inc., a biotechnology company focused on developing new cancer immunotherapy products.

President of Innovata BioConsulting. Providing consultation related to medical products with a focus on translational research, product development and product registration programs.

Former Vice President of Scientific and Clinical Affairs and Chief Science Officer/Blood Bank Technologies, for Terumo BCT transfusion medicine business.

Former Vice President/Chief Science Officer for CaridianBCT Biotechnologies, a division of CaridianBCT and formerly known as Navigant Biotechnologies.

Founder of Navigant Biotechnologies and CryoPharm Corporation.

I worked in the medical industry for 29 years during which I have managed technical staff and development programs in the fields of blood preservation, processing and pathogen reduction technologies.

I am an active member of several professional organizations including the American Chemical Society, the AABB and the International Society of Blood Transfusion. I have also held a position as an Adjunct Professor of Chemistry at The Ohio State University since 2005.

Specialties: Transfusion Medicine
Infectious Diseases
Translational Research
Research and Development